GenScript Biotech officially joins SBTi to fulfill its sustainability commitment By Investing.com - Investing.com UK

GNNSF Stock  USD 1.25  0.01  0.79%   
Roughly 61% of Genscript Biotech's investor base is looking to short. The analysis of overall sentiment of trading Genscript Biotech pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Genscript Biotech's historical and current headlines, can help investors time the market. In addition, many technical investors use Genscript Biotech stock news signals to limit their universe of possible portfolio assets.
Genscript Biotech pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Genscript daily returns and investor perception about the current price of Genscript Biotech as well as its diversification or hedging effects on your existing portfolios.
  
GenScript Biotech officially joins SBTi to fulfill its sustainability commitment By Investing.com Investing.com UK

Read at news.google.com
Google News at Macroaxis
  

Genscript Biotech Fundamental Analysis

We analyze Genscript Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genscript Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genscript Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Probability Of Bankruptcy

Probability Of Bankruptcy Comparative Analysis

Genscript Biotech is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Genscript Biotech Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Genscript Biotech pink sheet to make a market-neutral strategy. Peer analysis of Genscript Biotech could also be used in its relative valuation, which is a method of valuing Genscript Biotech by comparing valuation metrics with similar companies.

Peers

Genscript Biotech Related Equities

ICCCImmuCell   6.03   
0%
50.0%
TLPPFTelix Pharmaceuticals   5.40   
0%
45.0%
MRUSMerus BV   3.33   
0%
28.0%
KROSKeros Therapeutics   2.17   
0%
18.0%
IVBXFInnovent Biologics   0.62   
0%
5.0%
NUVLNuvalent   0.05   
0%
1.0%
NUVBNuvation Bio   0.76   
6.0%
0%
INBXInhibrx   0.88   
7.0%
0%
NXTCNextCure   0.92   
7.0%
0%
ZNTLZentalis Pharmaceuticals   1.28   
10.0%
0%
LCTXLineage Cell   1.92   
16.0%
0%
KRONKronos Bio   2.00   
16.0%
0%
CNTBConnect Biopharma   2.61   
22.0%
0%
OVIDOvid Therapeutics   2.83   
23.0%
0%
CVKDCadrenal Therapeutics,   3.45   
29.0%
0%
CRNXCrinetics Pharmaceuticals   3.52   
29.0%
0%
ONTTFOxford Nanopore   3.92   
33.0%
0%
LYELLyell Immunopharma   11.84   
100.0%
0%

Complementary Tools for Genscript Pink Sheet analysis

When running Genscript Biotech's price analysis, check to measure Genscript Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genscript Biotech is operating at the current time. Most of Genscript Biotech's value examination focuses on studying past and present price action to predict the probability of Genscript Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genscript Biotech's price. Additionally, you may evaluate how the addition of Genscript Biotech to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios